Immunome, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2018 | — | — | $1.7M |
| FY2019 | $1.8M | $5.1M | $2.5M |
| FY2020 | $3.2M | $44.5M | $39.8M |
| FY2021 | $9.7M | $57.9M | $49.2M |
| FY2022 | $7.4M | $24.0M | $20.3M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2018 | — | — | $1.7M |
| FY2019 | $1.8M | $5.1M | $2.5M |
| FY2020 | $3.2M | $44.5M | $39.8M |
| FY2021 | $9.7M | $57.9M | $49.2M |
| FY2022 | $7.4M | $24.0M | $20.3M |